Sprycel - analogs
Components: Dasatinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: 1388.4€ Instructions Sprycel | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Гликлазид Пролонг-АКОС ✘ (incl) Agel UMI ✘ (incl) Aggrenox ✘ (incl) Меркаптопурина моногидрат ✘ (incl) Axetin ✘ (incl) Ingitril ✘ (incl) Methyluracil suppositoriums ✘ (incl) Metoprolol-ratiopharm ✘ (incl) Anti-Oxidant ✘ (incl) Zido-H ✘ (incl) Д-Пантенол плюс антисептик ✘ (incl) Amezinium metilsulfate ✘ (incl) Liquiriton tablets ✘ (incl) Эхинацея Биокор Комплекс ✘ (incl) Вечернее Плюс Валериана+Пустырник ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Dasatinib-nativ Negative 🔍 | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 69% 1920€ Tasigna No 🔍 [Nilotinib]
- 69% — Nilotinib-nativ No 🔍 [Nilotinib]
- 69% — Нилотиниб No 🔍 [Nilotinib]
- 69% — Nilotinib hydrochloride monohydrate No 🔍 [Nilotinib]
- 64% — Lanvis Negative 🔍 [Tioguanine]
- 63% 229.9-1149.4€ Bosulif Negative 🔍 [Bosutinib]
- 62% — Imatinib-Actavis Negative 🔍 [Imatinib]
- 62% — Iimatinib mesilate Negative 🔍 [Imatinib]
- 62% — Citonib Negative 🔍 [Imatinib]
- 62% — Imatinib medac Negative 🔍 [Imatinib]
- 62% — Gistamel Negative 🔍 [Imatinib]
- 62% — Imagliv Negative 🔍 [Imatinib]
- 62% 324.5€ Иглиб Negative 🔍 [Imatinib]
- 62% — Imatinib-Alvogen Negative 🔍 [Imatinib]
- 54% — Калквенс Negative 🔍 [Akalabrutinib]
- 52% — Цитонибонко Negative 🔍 [Imatinib]
- 52% 271€ Neopax Negative 🔍 [Imatinib]
- 52% — Imatinib-TL Negative 🔍 [Imatinib]
- 52% 605€ Imatib Negative 🔍 [Imatinib]
- 52% — Imvec Negative 🔍 [Imatinib]
- 52% — Imatinib Grindex Negative 🔍 [Imatinib]
- 52% — Глемихиб Negative 🔍 [Imatinib]
- 52% — Imatinib Dr. Reddy s Negative 🔍 [Imatinib]
- 52% — Imatinib-Teva Negative 🔍 [Imatinib]
- 51% 115€ Vidaza Negative 🔍 [Azacitidine]
- 48% — Mercaptopurin-nativ Negative 🔍 [Mercaptopurine]
- 48% — Mercaptopurine tablets Negative 🔍 [Mercaptopurine]
- 48% 8.3€ Puri-Nethol Negative 🔍 [Mercaptopurine]
- 48% 6.7-7.4€ Mercaptopurin Negative 🔍 [Mercaptopurine]
- 46% 4850€ Imbruvica neutral [Ibrutinib]
- 46% 48.7€ Philachromin Negative 🔍 [Imatinib]
- 45% 2957.2€ Lemtrada Negative 🔍 [Alemtuzumab]
- 44% — Genfatinib Negative 🔍 [Imatinib]
- 44% — Албитиниб Negative 🔍 [Imatinib]
- 44% — Иматиниб-Сигардис Negative 🔍 [Imatinib]
- 44% — Imatinib Negative 🔍 [Imatinib]
- 44% — Neitrostim neutral [Filgrastim]
- 44% 25.9-28.6€ Neupogen neutral [Filgrastim]
- 41% 114.4-127.7€ Glivec Negative 🔍 [Imatinib]
- 41% 630€ Atriance Negative 🔍 [Nelarabine]
- 41% 45-106€ Рибомустин Negative 🔍 [Bendamustine]
- 41% — Неларабин Negative 🔍 [Nelarabine]
- 41% — Бозутиниб Negative 🔍 [Bosutinib]
- 41% 42.3-61€ Philachromin FS Negative 🔍 [Imatinib]
- 40% 73.4€ Venclexta No 🔍 [Venetoclax]
- 40% 14.6€ Myelastra neutral [Filgrastim]
- 40% 445.1€ Lonquex Unclear 🔍 [Lipegfilgrastim and more 1Proteine]
- 40% — Cytostadin neutral
- 39% — Цитозар НоваМедика Negative 🔍 [Cytarabine]
- 39% 6.1-7.6€ Cytosar Negative 🔍 [Cytarabine]
Learn more about the selection of analogues
- The drug has «Sprycel» 4 full analogs, for example Дазатиниб; 51 analog by action, the most similar - Tasigna (1920€).
- Medical online service has selected the best substitutes for Sprycel based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Sprycel analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.